Cargando…
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
Background: Constructed an immune-prognosis index (IPI) and divided lung adenocarcinoma (LUAD) patients into different subgroups according to IPI score, describe the molecular and immune characteristics of patients between different IPI subgroups, and explore their response to immune checkpoint bloc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124834/ https://www.ncbi.nlm.nih.gov/pubmed/35614936 http://dx.doi.org/10.3389/fphar.2022.818170 |